Gastrointestinal Disease Clinical Trial
— Endo-mmfiOfficial title:
Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases
Verified date | January 2024 |
Source | Beijing 302 Hospital |
Contact | Wei Shen |
Phone | +8615001038695 |
shshenw[@]sina.com | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
We plan the study to explore the application of endoscopic laser speckle imaging and multispectral blood oxygen imaging to observe gastrointestinal lesions, as well as the differences in the morphology, density and functional status of mucosal surfaces and deep blood vessels of different gastrointestinal lesions, also to explore the role of endoscopic multimodal functional imaging in common gastrointestinal diseases, especially in the early diagnosis of gastrointestinal tumors.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age: 18-80 years old, gender is not limited 2. Diagnosed or suspected of one of the following common gastrointestinal mucosal diseases: Chronic non-atrophic gastritis, chronic atrophic gastritis, gastric polyps, early gastric cancer, advanced gastric cancer, colon polyps, colon melanosis, inflammatory bowel disease, early colon cancer, advanced colon cancer 3. Sign the informed consent form - Exclusion Criteria: 1. Combined with cardiovascular and cerebrovascular diseases, or severe impairment of liver, kidney and hematopoietic system; 2. mentally ill; 3. the presence of bleeding disorders; 4. Platelet count<50×10^9/L; 5. Inability to tolerate or cooperate with endoscopy; 6. Patients with serious complications, such as severe infection, gastrointestinal bleeding, obstruction, perforation, etc.; 7. Pregnant or lactating women. 8. Refuse to sign the informed consent form |
Country | Name | City | State |
---|---|---|---|
China | The fifth Medical Center of Chinese PLA General Hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing 302 Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Image quality rate | The main evaluation index (image quality rate) is based on FAS(Full Analysis Set) and PPS(Per Protocol Set), for statistical description. Image quality rate Calculation formula: image excellent rate = number of cases with excellent or good image quality evaluation ÷ number of subjects undergoing multimodal endoscopy × 100%. | one year | |
Secondary | Diagnosis accuracy according to image | (1) Endoscopy examinations combined with laser speckle imaging and Doppler blood oxygen imaging can realize multi-level vascular observation and photographing of the mucosa, and the imaging analyzer will analyzes and synthesizes the two-dimensional map of laser speckle and blood oxygen imaging of the mucosa. Endoscopist will make diagnosis according to the image they get. (2) After endoscopic biopsy or endoscopic mucosal resection (EMR), endoscopic submucosal resection (ESD) obtaining tissue specimens, the pathology was observed by conventional HE staining or immunohistochemistry. (3) The results of comparison are divided into conformity, partial conformity and non-conformity. | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03566160 -
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
|
N/A | |
Active, not recruiting |
NCT05053191 -
Advancing Nursing Practices in Hospital Oncology Care
|
N/A | |
Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00910104 -
Cholestasis Reversal: Efficacy of IV Fish Oil
|
Phase 2/Phase 3 | |
Completed |
NCT05409196 -
Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults
|
Phase 1 | |
Enrolling by invitation |
NCT04719117 -
Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
|
||
Recruiting |
NCT03719209 -
Using Virtual Reality for Patients With Gastrointestinal Disease
|
N/A | |
Enrolling by invitation |
NCT03319446 -
Collection of Anonymized Samples
|
N/A | |
Enrolling by invitation |
NCT03234543 -
Remote Ischemic Conditioning in Abdominal Surgery
|
N/A | |
Completed |
NCT04498208 -
Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Completed |
NCT03549494 -
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
|
Phase 2 | |
Completed |
NCT03723447 -
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
|
Phase 4 | |
Not yet recruiting |
NCT04514042 -
Comparison of Zenker's Diverticulum Treatment Using Peroral Endoscopic Myotomy and Flexible Endoscopy Septotomy.
|
N/A | |
Suspended |
NCT04519086 -
The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30
|
N/A | |
Completed |
NCT03019042 -
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders
|
N/A | |
Completed |
NCT05008640 -
Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™
|
||
Completed |
NCT04671264 -
Efficacy and Safety of Vibrating Capsule in Patients With Functional Constipation
|
N/A |